Varenicline Tartrate Kit
Product Images NDC 68462-895

10 FDA label images from Glenmark Pharmaceuticals Inc., Usa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Varenicline Tartrate (NDC 68462-895). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructure (Chemicalstructure)

Chemicalstructure (Chemicalstructure)
Chemical structure of varenicline tartrate showing the molecular arrangement of its active ingredient.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A bar chart titled 'Continuous Abstinence, Weeks 9 through 12' illustrating abstinence rates from multiple studies comparing varenicline tartrate tablets (0.5 mg BID, 1.0 mg BID, flexible doses), bupropion SR 150 mg BID, and placebo. Bars show percentage abstinence with error bars, grouped by study number (2 to 5).*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A line graph titled 'Continuous Abstinence Rate during Nontreatment Follow-Up' showing percent continuous abstinent on the vertical axis and nontreatment follow-up duration in weeks on the horizontal axis. It compares Varenicline tablets 1.0 mg BID to placebo over 52 weeks, displaying a higher continuous abstinence rate for Varenicline tablets than placebo across the follow-up period.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A bar chart titled 'Continuous Abstinence, Weeks 9 through 52' comparing the percentage of continuous abstinence among groups taking varenicline tartrate tablets (0.5 mg and 1 mg) and placebo across multiple studies (Study 2, Study 3, Study 4, and Study 5). The x-axis lists treatment groups with their dosages; the y-axis shows percentages from 0% to 35%. Error bars indicate variability in the data for each group.*
FDA Label Image
FDA Label Image

Logo1 (Logo1)

FDA Label Image

Starter-carton-pack (Starter Carton Pack)

Starter-carton-pack (Starter Carton Pack)
Packaging label for varenicline tartrate tablets, film coated, available as a starting month box containing a 4-week supply. The label details the dosage strengths of 0.5 mg and 1 mg tablets and provides dosage instructions for the first 3 weeks and onward. Distributed by Glenmark Pharmaceuticals Inc., USA, the label includes storage instructions, a barcode, and references to the Medication Guide. The product is indicated for oral use and is labeled Rx only.*
FDA Label Image

Starter-blister-wallet-pack (Starter Blister Wallet Pack)

Starter-blister-wallet-pack (Starter Blister Wallet Pack)
Packaging label for varenicline tartrate tablets by Glenmark Pharmaceuticals Inc., USA. The label includes the product name 'Varenicline Tablets' and NDC 68462-895-04. It is a starting pack containing a calendar card for dosing: 1 starting week of 0.5 mg tablets and 3 continuing weeks of 1 mg tablets. The tablets are oral, film-coated, prescription-only, with instructions for patient use.*
FDA Label Image

0-5mg-56-bottles (0 5mg 56 Bottles)

0-5mg-56-bottles (0 5mg 56 Bottles)
Label for Varenicline Tablets 0.5 mg by Glenmark Pharmaceuticals Inc., USA. The label indicates a quantity of 56 film-coated tablets, with storage instructions and medication guide dispensing information. The barcode and product origin (India) are also visible.*
FDA Label Image

1mg-56-bottles (1mg 56 Bottles)

1mg-56-bottles (1mg 56 Bottles)
Label for Varenicline Tablets 1 mg film-coated tablets by Glenmark Pharmaceuticals Inc., USA. The package contains 56 tablets. The label includes storage instructions, dispensing warnings, and a barcode. The product is labeled for prescription use only and is produced in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.